Pharmacokinetic interaction between acetaminophen and lansoprazole

被引:13
作者
Sanaka, M
Kuyama, Y
Mineshita, S
Qi, JF
Hanada, Y
Enatsu, I
Tanaka, H
Makino, H
Yamanaka, M
机构
[1] Nihon Univ, Sch Med, Dept Internal Med, Itabashi Ku, Tokyo 173, Japan
[2] Tokyo Med & Dent Univ, Med Res Inst, Dept Prevent Med, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Med Res Inst, Div Social Med, Tokyo, Japan
关键词
acetaminophen; lansoprazole; gastric emptying; absorption; elimination;
D O I
10.1097/00004836-199907000-00014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Because of its minimal gastric toxicity, acetaminophen is the analgesic of choice for patients with gastric acid-related disorders. Because proton pump inhibitors an widely used, concomitant prescription of acetaminophen and lansoprazole would be prevalent. This crossover study was conducted to investigate an acetaminophen-lansoprazole interaction. On one occasion, each of six healthy, fasted, male volunteers ingested 1.0 g acetaminophen dissolved in 200 mt water. On another occasion. at least 1 week apart. 30 mg lansoprazole was administered orally, simultaneously with acetaminophen, after pretreatment with the same dose of lansoprazole once daily for 2 days. Plasma acetaminophen concentrations were measured at 0, 0.25, 0.5, 0.75, 1, 2, 3, 5, and 8 hours after dosing. The peak plasma concentration of acetaminophen and the time to its occurrence were significantly higher and shorter, respectively, during the lansoprazole session than during the control session. Neither the elimination half-life nor the area under the curve was significantly different between the two sessions. Lansoprazole hastens the absorption of acetaminophen solution, but little modifies its elimination rate and bioavailability.
引用
收藏
页码:56 / 58
页数:3
相关论文
共 22 条
[1]   Pharmacokinetics, metabolism and interactions of acid pump inhibitors - Focus on omeprazole, lansoprazole and pantoprazole [J].
Andersson, T .
CLINICAL PHARMACOKINETICS, 1996, 31 (01) :9-28
[2]   Omeprazole causes delay in gastric emptying of digestible meals [J].
Benini, L ;
Castellani, G ;
Bardelli, E ;
Sembenini, C ;
Brentegani, MT ;
Caliari, S ;
Vantini, I .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (03) :469-474
[3]   OMEPRAZOLE IS AN ARYL HYDROCARBON-LIKE INDUCER OF HUMAN HEPATIC CYTOCHROME-P450 [J].
DIAZ, D ;
FABRE, I ;
DAUJAT, M ;
SAINTAUBERT, B ;
BORIES, P ;
MICHEL, H ;
MAUREL, P .
GASTROENTEROLOGY, 1990, 99 (03) :737-747
[4]  
ENDRENYI L, 1991, INT J CLIN PHARM TH, V29, P394
[5]   CLINICAL PHARMACOKINETICS OF PARACETAMOL [J].
FORREST, JAH ;
CLEMENTS, JA ;
PRESCOTT, LF .
CLINICAL PHARMACOKINETICS, 1982, 7 (02) :93-107
[6]  
HALVORSEN L, 1973, SCAND J GASTROENTERO, V8, P395
[7]   DEPENDENCE OF PARACETAMOL ABSORPTION ON RATE OF GASTRIC EMPTYING [J].
HEADING, RC ;
NIMMO, J ;
PRESCOTT, LF ;
TOTHILL, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1973, 47 (02) :415-421
[8]   THE EFFECT OF OMEPRAZOLE ON GASTRIC-EMPTYING IN PATIENTS WITH DUODENAL-ULCER DISEASE [J].
HOROWITZ, M ;
HETZEL, DJ ;
BUCKLE, PJ ;
CHATTERTON, BE ;
SHEARMAN, DJC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (05) :791-794
[9]  
Ko JW, 1997, DRUG METAB DISPOS, V25, P853
[10]  
MELZER E, 1995, EUR J DRUG METAB PH, V20, P125